This observational study, a multicenter retrospective cohort database study, carried out in two medical centers, Centro Medico Bournigal (CMBO) in Puerto Plata and Centro Medico Punta Cana (CMPC) in Punta Cana, Dominican Republic, sought to determine whether Ivermectin, at a weekly orally dose of 0.2 mg/kg, is an effective pre-exposure prophylactic method (PrEP) for the spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), in the healthcare workers. The study began on June 29, 2020 and ended on July 26, 2020 (4 weeks).
Study Type
OBSERVATIONAL
Enrollment
713
Ivermectin weekly oral dose 0.2 mg/kg equivalent for 4 weeks
Centro Medico Bournigal
Puerto Plata, Dominican Republic
Centro Médico Punta Cana
Punta Cana, Dominican Republic
Number of participants RT-PCR positive for Covid-19
Workers confirmed Covid-19 through Reverse Transcription Polymerase Chain Reaction (RT-PCR) test
Time frame: 4 weeks
Number of sick participants who condition deteriorated
Workers infected with Covid-19, confirmed with RT-PCR and required hospitalization and/or ICU
Time frame: 4 weeks
Number of sick participants who died
Workers infected with Covid-19, confirmed with RT-PCR and died.
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.